<DOC>
	<DOCNO>NCT01638923</DOCNO>
	<brief_summary>To evaluate efficacy safety combine oral contraceptive estradiol valerate dienogest treatment heavy menstrual bleeding</brief_summary>
	<brief_title>Study 4-phasic Oral Contraceptive Treatment Heavy Menstrual Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Women 18 year old generally good health diagnosis heavy menstrual bleeding without organic pathology , request contraception Willingness use barrier contraception ( e.g. , condom ) screen study completion Willingness use collect sanitary protection ( pads tampon ) provide sponsor compatible alkaline hematin test throughout study completion Current diagnosis organic uterine bleed History endometrial ablation , dilatation curettage within 2 month Visit 1 . Clinically significant pelvic finding ( whether confirm transvaginal ultrasound [ TVU ] ) . Clinically significant abnormal result breast examination ( breast palpation ) . Positive pregnancy test Visit 1 Less three month since delivery , abortion , lactation start Visit 1 Other contraceptive method Any disease condition may worsen hormonal treatment Smokers age 35 Body mass index &gt; 32</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Heavy Menstrual Bleeding</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
	<keyword>Oral contraceptive</keyword>
	<keyword>Estradiol valerate</keyword>
	<keyword>Dienogest</keyword>
</DOC>